α-Synuclein inhibitor 9 is an α-synuclein inhibitor that binds to cavities in mature α-synuclein fibrils and reduces β-sheet structures; it inhibits A53T α-synuclein aggregation, exhibits neuroprotective effects, improves brain functional connectivity, alleviates motor dysfunction, and is useful in Parkinson’s disease (PD) research.